ArticleAntimicrobial agents and chemotherapy2016

Pharmacokinetics of the New Hepatitis C Virus NS3 Protease Inhibitor Narlaprevir following Single-Dose Use with or without Ritonavir in Patients with Liver Cirrhosis.

V Isakov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.